Vivos Therapeutics, Inc. (VVOS)
0.2249
-0.03
(-12.96%)
USD |
NASDAQ |
Aug 28, 16:00
0.3842
+0.16
(+70.83%)
After-Hours: 06:19
Vivos Therapeutics Cash from Investing (Quarterly) : -0.416M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.416M |
| March 31, 2026 | -0.018M |
| December 31, 2025 | -1.581M |
| September 30, 2025 | 0.083M |
| June 30, 2025 | -5.906M |
| March 31, 2025 | -0.122M |
| December 31, 2024 | -0.165M |
| September 30, 2024 | -0.192M |
| June 30, 2024 | -0.06M |
| March 31, 2024 | -0.151M |
| December 31, 2023 | -0.165M |
| September 30, 2023 | -0.154M |
| June 30, 2023 | -0.245M |
| March 31, 2023 | -0.289M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.20M |
| September 30, 2022 | -0.10M |
| June 30, 2022 | -0.504M |
| March 31, 2022 | -0.12M |
| December 31, 2021 | -0.3823M |
| September 30, 2021 | -0.432M |
| June 30, 2021 | -1.532M |
| March 31, 2021 | -0.2617M |
| December 31, 2020 | -0.0952M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -0.0052M |
| December 31, 2019 | 0.1744M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Hinge Health, Inc. | 28.62M |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.015M |
| Haemonetics Corp. | -22.23M |
| Pro-Dex, Inc. | -5.055M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.148M |
| Cash from Financing (Quarterly) | 3.228M |
| Free Cash Flow | -19.01M |
| Free Cash Flow Per Share (Quarterly) | -0.2016 |
| Free Cash Flow to Equity (Quarterly) | -3.801M |
| Free Cash Flow to Firm (Quarterly) | -2.464M |
| Free Cash Flow Yield | -643.3% |